跳至主要内容
临床试验/JPRN-UMIN000048438
JPRN-UMIN000048438招募中2 期

An effect of azithromycin for exacerbation in asthma patients with obesity: the protocol for a multi-center, prospective single-arm intervention study - An effect of azithromycin for exacerbation in asthma patients with obesity

Saga University0 个研究点目标入组 50 人开始时间: 2022年7月22日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria will be: patients whose aspartate aminotransferase or alanine aminotransferase at more than 100 IU/L, creatinine at 2.0 mg/dL, who have life threatened arrhythmia or paroxysmal tachycardia at more than 100 times per minute of heart rate, who had been admitted by acute myocardial infarction or heart failure in previous year, who diagnosed malignancy in previous 5 years except for complete remission after the treatment, who treated by macrolide antibiotics in previous 4 week and biologics including omalizumab, mepolizumab, benralizumab, dupilumab in previous 8 weeks at initiation of the intervention of azithromycin in present study, whose QT interval requires correction for heart rate at more than 480 ms, who are pregnant or under breastfeeding, whose BMI at less than 25 kg/m2, and who decided ineligible for present study by researchers.

研究者

相似试验